Settergren, Magnus <br/><br/>
Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.  [electronic resource] 

 -  European heart journal  Jul 2008 
 - 1753-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-9645 
<br/><br/><label>Standard No.: </label>10.1093/eurheartj/ehn166  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Azetidines--pharmacology<br/>Brachial Artery--drug effects<br/>Cholesterol--blood<br/>Coronary Disease--blood<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Angiopathies--blood<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Endothelium, Vascular--drug effects<br/>Ezetimibe<br/>Female<br/>Forearm--blood supply<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Hyperglycemia--blood<br/>Inflammation Mediators--blood<br/>Lipids--blood<br/>Male<br/>Middle Aged<br/>Plethysmography--methods<br/>Regional Blood Flow--drug effects<br/>Simvastatin--pharmacology<br/>Vasodilation--drug effects